New therapeutics in alzheimer’s disease longitudinal cohort study (ntad): study protocol

HIGHLIGHTS

• who: Yun-u00adJu Cheng et al. from the (UNIVERSITY) have published the Article: New Therapeutics in Alzheimeru2019s Disease Longitudinal Cohort study (NTAD): study protocol, in the Journal: BMJ Open 2022;12:e055135. of /2022/
• what: Positron emission tomography (PET) can quantify and localise Alzheimer pathology through the use of New Therapeutics in Alzheimer`s Disease Longitudinal Cohort study (NTAD): study protocol Research aims The aim is to identify a biomarker set from neurophysiological M/EEG sensitive to the presence and progression of Alzheimer`s disease, in support of experimental medicine studies. The authors aim to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.